Department of Interdisciplinary Program in Biomedical Science Major, Graduate School, Soonchunhyang University, Asan 31538, Republic of Korea.
Department of Microbiology, College of Medicine, Soonchunhyang University, Cheonan 33151, Republic of Korea.
Int J Mol Sci. 2024 Sep 23;25(18):10223. doi: 10.3390/ijms251810223.
Although coronary artery occlusion can have a negative effect on the myocardium, chronic total occlusion (CTO) exhibits different clinical features from those of acute myocardial infarction (AMI). In this study, we identify the differential associations of exosomal miRNAs with CTO and AMI. Exosomes were isolated from the plasma obtained from coronary arteries of patients undergoing percutaneous coronary intervention to treat CTO (n = 29) and AMI (n = 24), followed by small RNA sequencing, target gene predictions, and functional enrichment analyses. Promising miRNA markers were validated using real-time PCR in 35 CTO, 35 AMI, and 10 normal subjects. A total of 205 miRNAs were detected in all subjects, and 20 and 12 miRNAs were upregulated and downregulated in CTO compared to AMI patients, respectively (|fold change| > 4, FDR q < 0.05). The target genes of miRNAs that were higher in CTO patients were associated with "regulation of cell cycle phase transition", "cell growth", and "apoptosis". The target genes of miRNAs that were lower in CTO patients were enriched in terms such as "muscle cell differentiation", "response to oxygen levels", and "artery morphogenesis". On qRT-PCR analysis, the expression levels of miR-9-5p and miR-127-3p were significantly different between CTO and AMI patients. The miRNA expression levels accurately distinguished CTO from AMI patients with 79% specificity and 97% sensitivity. The miRNA contents of plasma exosomes were significantly different between CTO and AMI patients. The miRNAs may play important roles in CTO and AMI.
虽然冠状动脉闭塞会对心肌产生负面影响,但慢性完全闭塞(CTO)与急性心肌梗死(AMI)的临床特征不同。在本研究中,我们确定了外泌体 miRNA 与 CTO 和 AMI 的差异关联。从接受经皮冠状动脉介入治疗以治疗 CTO(n = 29)和 AMI(n = 24)的患者的冠状动脉血浆中分离出外泌体,随后进行小 RNA 测序、靶基因预测和功能富集分析。使用实时 PCR 在 35 例 CTO、35 例 AMI 和 10 例正常对照中验证了有前途的 miRNA 标志物。所有受试者共检测到 205 个 miRNA,与 AMI 患者相比,CTO 患者上调和下调的 miRNA 分别有 20 个和 12 个(|fold change| > 4,FDR q < 0.05)。CTO 患者中高表达的 miRNA 的靶基因与“细胞周期相过渡的调节”、“细胞生长”和“细胞凋亡”有关。CTO 患者中低表达的 miRNA 的靶基因富集在“肌细胞分化”、“对氧水平的反应”和“动脉形态发生”等术语中。在 qRT-PCR 分析中,miR-9-5p 和 miR-127-3p 在 CTO 和 AMI 患者之间的表达水平差异显著。miRNA 表达水平可准确区分 CTO 和 AMI 患者,特异性为 79%,敏感性为 97%。CTO 和 AMI 患者血浆外泌体中的 miRNA 含量差异显著。这些 miRNA 可能在 CTO 和 AMI 中发挥重要作用。